Healthcare and antiretroviral treatment in HIV-infected detained persons at the penitentiary units

被引:0
|
作者
Cholewinska, Grazyna [1 ]
机构
[1] Hosp Infect Dis Warsaw, HIV Warsaw Penitentiary Dept, Warsaw, Poland
来源
HIV & AIDS REVIEW | 2008年 / 7卷 / 04期
关键词
HIV infection; prisons; antiretroviral therapy; healthcare in prison;
D O I
10.1016/S1730-1270(10)60016-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There has been an increase rate of HIV prevalence among prison population in Poland.. The prevalence of HIV infection in Polish prisons is 1,54 percent out of detained population. Total number of HIV/AIDS was 1145 prisoners in 2007, and 81 new cases was detected during imprisoning. HIV-positive injection drug users (IDU's) are a special category of patients whose access to treatment is limited by economic and addiction barriers, out of the prison walls. Recent studies in Central and Eastern Europe show that even with the wide availability of antiretroviral (ARV) medications, only 40 percent of IDU's received HAART. The situation is more alarming in Russia and other fSU, where less than 1 percent of HIV-positive drug users receiving ARV treatment. In Poland HIV-infected prisoners have been regularly monitored on the specialist visits, and they could voluntarily opt out of HIV tested, as well as HCV, HBV, syphilis, etc. Design of antiretroviral regimen in prison can be arrange precisely for long-term period. Directly administrated antiretroviral therapy is the best method for non-adherent patients, especially for IDU's in prison.
引用
收藏
页码:10 / 12
页数:3
相关论文
共 50 条
  • [1] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    AIDS, 2002, 16 (01) : 75 - 83
  • [2] Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons
    Bialy, Michal
    Czarnecki, Marcin
    Inglot, Malgorzata
    VIRUSES-BASEL, 2023, 15 (12):
  • [3] The treatment of tuberculosis in HIV-infected persons
    Pozniak, AL
    Miller, R
    Ormerod, LP
    AIDS, 1999, 13 (04) : 435 - 445
  • [4] Treatment of dyslipidaemia in HIV-infected persons
    Manuel, O
    Thiébaut, R
    Darioli, R
    Tarr, PE
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (10) : 1619 - 1645
  • [5] Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons
    Chao, Chun
    Leyden, Wendy A.
    Xu, Lanfang
    Horberg, Michael A.
    Klein, Daniel
    Towner, William J.
    Quesenberry, Charles P., Jr.
    Abrams, Donald I.
    Silverberg, Michael J.
    AIDS, 2012, 26 (17) : 2223 - 2231
  • [6] TREATMENT AND PREVENTION OF TUBERCULOSIS IN HIV-INFECTED PERSONS
    COHN, DL
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1994, 8 (02) : 399 - 412
  • [7] Efficacy of antiretroviral therapy among HIV-infected prisoners treated with Directly Administration of Antiretroviral Treatment (DAART) method in Warsaw Penitentiary Department
    Cholewinska, Grazyna
    HIV & AIDS REVIEW, 2008, 7 (04): : 13 - 15
  • [8] Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment
    Pettit, A. C.
    Barkanic, G.
    Stinnette, S.
    Rebeiro, P.
    Blackwell, R.
    Raffanti, S. P.
    Shepherd, B. E.
    Sterling, T. R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (03) : 355 - 359
  • [9] Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance
    Stein, MD
    Urdaneta, ME
    Clarke, J
    Maksad, J
    Sobota, M
    Hanna, L
    Markson, LE
    JOURNAL OF ADDICTIVE DISEASES, 2000, 19 (01) : 85 - 94
  • [10] Results of early antiretroviral therapy and mortality among HIV-Infected persons
    Krasnov, M.
    Cherkasov, A.
    Kojevnikova, I
    Velykodanov, G.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 105 - 105